Cancer treatment

Details for Australian Patent Application No. 2010308030 (hide)

Owner Pfizer Inc.

Inventors Huang, Bo; Marshall, Margaret Ann

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010308030

PCT Pub. Number WO2011/045704

Priority 61/250,711 12.10.09 US

Filing date 4 October 2010

Wipo publication date 21 April 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/045704 Priority application(s): WO2011/045704

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010308036-Brewing unit for coffee brewing

2010308028-Pyrrolo[2,3-d] pyrimidine compounds